Current stage?-Stage I - Page 13 of 24 Posts on Medivizor
Navigation Menu

Current stage?-Stage I Posts on Medivizor

Risk factors for disease reclassification in prostate cancer patients on active surveillance

Risk factors for disease reclassification  in prostate cancer patients on active surveillance

Posted by on Jul 16, 2015 in Prostate cancer | 0 comments

In a nutshell The authors determined the risk factors that led to disease reclassification (change in grade/status of the disease) in prostate cancer patients under active surveillance. Some background Active surveillance is common in early-stage prostate cancer management. It involves active monitoring of patients for any changes in symptoms or...

Read More

Cancer sub-types; what are the characteristics?

Cancer sub-types; what are the characteristics?

Posted by on Jun 24, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to distinguish whether the characteristics of breast cancer could depend on the focality of the tumor. Some background Breast cancer can be characterized as 'unifocal', 'multifocal and 'multicentric'. This refers to the number of areas in which the cancer can be found (focality); unifocal...

Read More

Breast cancer in elderly women; can trastuzumab treatment increase the risk of heart failure?

Breast cancer in elderly women; can trastuzumab treatment increase the risk of heart failure?

Posted by on Jun 24, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to determine the risks of developing cardiac or heart problems while being treated with trastuzumab (Herceptin) for breast cancer. Some background Trastuzumab is a form of endocrine or hormone therapy used to treat patients with human epidermal growth factor 2 positive (HER2+) breast cancer. Since the approval of...

Read More

Weight gain on hormone therapy

Weight gain on hormone therapy

Posted by on Jun 20, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine factors associated with weight gain in patients who received hormone therapy.   Some background Hormone therapy is a common treatment used in prostate cancer. It targets hormones active in prostate cancer, such as testosterone. Some patients might experience weight gain following...

Read More

Can immune cells predict lung cancer outcomes?

Can immune cells predict lung cancer outcomes?

Posted by on Jun 19, 2015 in Lung cancer | 0 comments

In a nutshell This study looked at the association between the lymphocyte-monocyte ratio (LMR) in patients' blood and their lung cancer outcome. Some background Lung cancer is one of the most common cancers worldwide. Despite improvements in treatment outcomes are still quite poor. Therefore early detection and treatment is...

Read More

Can hormone therapy increase the risk of heart disease and diabetes in prostate cancer?

Can hormone therapy increase the risk of heart disease and diabetes in prostate cancer?

Posted by on Jun 13, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the link between hormone therapy and metabolic syndrome in prostate cancer patients.  Some background Hormone therapy is a common treatment used in prostate cancer management. It blocks the male sex hormones active in prostate cancer, such as testosterone. In some patients hormone therapy can...

Read More